Outlook Therapeutics:

Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg; bevacizumab gamma) to enhance the standard of care for bevacizumab for the treatment of retina diseases. LYTENAVA™ (bevacizumab gamma) is the first ophthalmic formulation of bevacizumab to receive European Commission and MHRA Marketing Authorization for the treatment of wet AMD. Outlook Therapeutics commenced commercial launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK as a treatment for wet AMD.

In the United States, ONS-5010/LYTENAVA™ (bevacizumab-vikg) is investigational, and a BLA has been resubmitted to the FDA. If approved in the United States, ONS-5010/LYTENAVA™, would be the first approved ophthalmic formulation of bevacizumab for use in retinal indication

Opportunity and Summary of Position:

The Vice President of Market Access will lead the development and execution of the global market access strategy for LYTENAVA™ (bevacizumab gamma) and future pipeline assets in retinal diseases. As the company expands its presence in ophthalmology, this executive will ensure optimal pricing, reimbursement, and patient access across key markets including the U.S., EU, and UK. The role will be pivotal in shaping the commercial success of the first ophthalmic formulation of bevacizumab approved for wet AMD, navigating the competitive anti-VEGF landscape, and supporting lifecycle management and global expansion.

Reporting Relationships:

The VP of Market Access will report to the Chief Commercial Officer (CCO).

Position Responsibilities:

Strategic Leadership

  • Define and execute the global market access and pricing strategy for LYTENAVA™, aligned with the company’s commercial and medical strategy.
  • Serve as a key member of the executive Commercial leadership team, contributing to global brand planning, commercial decision-making, and long-range forecasting.
  • Build and lead a high-performing Market Access team, including functions such as global pricing, HEOR, reimbursement, policy, and payer engagement.

Market Access Execution

  • Drive successful reimbursement and formulary inclusion across U.S., EU, and international markets, leveraging strong value propositions and real-world evidence.
  • Collaborate with regional teams to navigate payer negotiations, HTA submissions, and local access requirements.
  • Partner closely with cross-functional teams (Regulatory, Medical Affairs, Marketing, Clinical Development) to align access planning with product development milestones.

Pricing and Reimbursement

  • Develop differentiated pricing strategies that reflect product value while supporting market penetration and access.
  • Monitor competitive pricing and reimbursement trends in the ophthalmology and anti-VEGF space (e.g., aflibercept, ranibizumab, biosimilars).
  • Ensure compliance with global pricing and transparency regulations (e.g., EU ERP rules, price reporting, U.S. ASP and Medicaid best price).

Payer & Stakeholder Engagement

  • Cultivate relationships with key stakeholders, including payers, HTA bodies, ophthalmology KOLs, and policy influencers.
  • Lead development of compelling payer value dossiers, economic models (e.g., cost-effectiveness, budget impact), and real-world data strategies.

Health Economics & Real-World Evidence (HEOR)

  • Oversee the generation of health economic and outcomes evidence to support value demonstration, including RWE from ophthalmic practice settings.
  • Ensure evidence strategy supports reimbursement and policy needs across markets with distinct HTA frameworks (e.g., NICE, G-BA, HAS).

Candidate Qualifications:

The company is seeking an individual with the following qualifications and who is willing to make a long-term commitment to the organization:

Education/Certification

Advanced degree in a relevant field (e.g., MBA, MPH, PhD, PharmD, MD) preferred.

Qualifications and Skills

  • 15+ years of experience in market access, pricing, HEOR, or related roles in the pharmaceutical or biotech industry.
  • Demonstrated success securing global market access for specialty or ophthalmic products, ideally within retina/anti-VEGF therapies.
  • Strong knowledge of the EU and U.S. market access landscape, including HTA processes and payer decision-making.
  • Proven ability to build and lead high-performing cross-functional teams.
  • Strategic mindset with deep understanding of health systems and payer drivers.
  • Strong leadership, negotiation, and communication skills.
  • Ability to manage complexity in a competitive therapeutic landscape and lead through ambiguity.
  • High ethical standards and commitment to compliance, especially around pricing and access policies.

Compensation

An attractive compensation package will be offered to the successful candidate. It will include a competitive base salary and incentive bonus. A benefits package customary to the position will also be provided including 401k match, medical and dental.

How to apply

Please send an email with your resume to hr@outlooktherapeutics.com

Outlook Therapeutics is an equal opportunity employer.